Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Receivables - Other: 2020-2023

Historic Receivables - Other for Mereo BioPharma Group (MREO) over the last 3 years, with Dec 2023 value amounting to $1.9 million.

  • Mereo BioPharma Group's Receivables - Other was N/A to $1.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2023, which is N/A change from last year.
  • Per Mereo BioPharma Group's latest filing, its Receivables - Other stood at $1.9 million for FY2023, which was up 1.94% from $1.9 million recorded in FY2021.
  • In the past 5 years, Mereo BioPharma Group's Receivables - Other registered a high of $1.9 million during FY2023, and its lowest value of $1.3 million during FY2020.
  • In the last 2 years, Mereo BioPharma Group's Receivables - Other had a median value of $1.9 million in 2021 and averaged $1.9 million.
  • Data for Mereo BioPharma Group's Receivables - Other shows a peak YoY spiked of 46.61% (in 2021) over the last 5 years.
  • Mereo BioPharma Group's Receivables - Other (Yearly) stood at $1.3 million in 2020, then skyrocketed by 46.61% to $1.9 million in 2021, then reached $1.9 million in 2023.